Relay Therapeutics, Inc. has grown revenue 122% a year over three years and −29% a year over five. Revenue growth, 3-year annual rate: +122% (Biotechnology median +17%). Revenue growth, 5-year rate: −29%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

RLAYRelay Therapeutics, Inc.

Healthcare

$17.88+284% 1Y

$17.88

$4.3852 weeks$20.77

Is it growing?

Good

Revenue growing +24% year on year. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Revenue trend+24% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RLAY growing?

Relay Therapeutics, Inc. has grown revenue 122% a year over three years and −29% a year over five.

+122%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −29%
Revenue growth, 5-year rate · +122% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›